GB0012231D0 - Gene expression system - Google Patents

Gene expression system

Info

Publication number
GB0012231D0
GB0012231D0 GB0012231A GB0012231A GB0012231D0 GB 0012231 D0 GB0012231 D0 GB 0012231D0 GB 0012231 A GB0012231 A GB 0012231A GB 0012231 A GB0012231 A GB 0012231A GB 0012231 D0 GB0012231 D0 GB 0012231D0
Authority
GB
United Kingdom
Prior art keywords
gene expression
expression system
gene
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB0012231A
Other versions
GB2362383B (en
GB2362383A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Devgen NV
Original Assignee
Devgen NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Devgen NV filed Critical Devgen NV
Priority to GB0012231A priority Critical patent/GB2362383B/en
Publication of GB0012231D0 publication Critical patent/GB0012231D0/en
Priority to AU75671/01A priority patent/AU7567101A/en
Priority to PCT/EP2001/005794 priority patent/WO2001088114A2/en
Publication of GB2362383A publication Critical patent/GB2362383A/en
Application granted granted Critical
Publication of GB2362383B publication Critical patent/GB2362383B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/75Vector systems having a special element relevant for transcription from invertebrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/44Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
    • C12N2840/445Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor for trans-splicing, e.g. polypyrimidine tract, branch point splicing

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
GB0012231A 2000-05-19 2000-05-19 Gene expression system Expired - Fee Related GB2362383B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0012231A GB2362383B (en) 2000-05-19 2000-05-19 Gene expression system
AU75671/01A AU7567101A (en) 2000-05-19 2001-05-18 Gene expression system
PCT/EP2001/005794 WO2001088114A2 (en) 2000-05-19 2001-05-18 Gene expression system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0012231A GB2362383B (en) 2000-05-19 2000-05-19 Gene expression system

Publications (3)

Publication Number Publication Date
GB0012231D0 true GB0012231D0 (en) 2000-07-12
GB2362383A GB2362383A (en) 2001-11-21
GB2362383B GB2362383B (en) 2003-12-31

Family

ID=9891998

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0012231A Expired - Fee Related GB2362383B (en) 2000-05-19 2000-05-19 Gene expression system

Country Status (3)

Country Link
AU (1) AU7567101A (en)
GB (1) GB2362383B (en)
WO (1) WO2001088114A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2513336A1 (en) 1998-03-20 1999-09-30 Benitec Australia Ltd. Control of gene expression in a non-human eukaryotic cell, tissue or organ
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
AU776150B2 (en) 1999-01-28 2004-08-26 Medical College Of Georgia Research Institute, Inc. Composition and method for (in vivo) and (in vitro) attenuation of gene expression using double stranded RNA
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
EP1229134A3 (en) 2001-01-31 2004-01-28 Nucleonics, Inc Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135855A (en) * 1986-09-03 1992-08-04 The United States Of America As Represented By The Department Of Health And Human Services Rapid, versatile and simple system for expressing genes in eukaryotic cells
DE69636937T3 (en) * 1995-12-15 2011-01-05 Virxsys Corp. THERAPEUTIC MOLECULES OBTAINED BY TRANS-CLEARANCE
US6280978B1 (en) * 1995-12-15 2001-08-28 Intronn Holdings, Llc Methods and compositions for use in spliceosome mediated RNA trans-splicing
WO1999037770A1 (en) * 1998-01-23 1999-07-29 Cold Spring Harbor Laboratory Phagocytosis genes and uses thereof
GB9827152D0 (en) * 1998-07-03 1999-02-03 Devgen Nv Characterisation of gene function using double stranded rna inhibition
DE60038045T2 (en) * 1999-11-05 2009-02-05 Jena Bioscience Gmbh NON-PATHOGEN KINETOPLASTIDE PROTEIN EXPRESSION SYSTEM

Also Published As

Publication number Publication date
GB2362383B (en) 2003-12-31
AU7567101A (en) 2001-11-26
WO2001088114A3 (en) 2002-06-20
GB2362383A (en) 2001-11-21
WO2001088114A2 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
EG22812A (en) Depwater intervention system
AU7001701A (en) Liveexception system
GB0016702D0 (en) Expression system
GB9925459D0 (en) Gene silencing
HUP0201438A3 (en) Dna vaccine - pcv
EP1320539A4 (en) Electrophoresis system
GB0019745D0 (en) Gene expression element
GB2366895B (en) Ticketless system
HUP0105208A3 (en) Gene therapy-1
GB0007651D0 (en) Gene sequence
AU6424701A (en) Gasc1 gene
IL146332A0 (en) PrP-LIKE GENE
SG89406A1 (en) Carrying system
GB2362383B (en) Gene expression system
GB0013289D0 (en) Location system
AU2001247444A1 (en) Erbeta-mediated gene expression
AU2001289885A8 (en) Air-preparation system
GB0021667D0 (en) Genetic study
EP1215284A4 (en) Tsg-like gene
GB9905644D0 (en) Dna
GB0016699D0 (en) Expression system
GB2372023B (en) Torque-biasing system
GB0029357D0 (en) Tolerance gene
GB9912543D0 (en) Gene
GB9910522D0 (en) Gene

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20070519